Lidocaine Accord

Lidocaine Hydrochloride, the active ingredient in Lidocaine Accord, is a local anesthetic presented as a sterile solution for epidural, intramuscular, intravenous use. It provides rapid onset of nerve block for minor surgical procedures, epidural analgesia and management of ventricular arrhythmias.

GNH USA supplies Lidocaine Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lidocaine Accord, a local anesthetic, is used to provide analgesia by blocking nerve conduction in various clinical settings.

- Minor surgical procedures: provides local anesthesia to facilitate painless incision and excision. - Epidural analgesia: delivers regional pain relief during labor or postoperative periods. - Ventricular arrhythmias: used intravenously to stabilize cardiac rhythm in emergency settings.

Adverse reactions may occur following administration of Lidocaine Accord.

Common Side Effects: - Transient burning or tingling at the injection site - Mild hypotension - Dizziness or light‑headedness - Nausea or vomiting

Serious or Rare Side Effects: - Anaphylactic or severe allergic reaction - Cardiac conduction abnormalities such as heart block or severe bradycardia - Methemoglobinemia - Central nervous system toxicity including seizures or loss of consciousness

Lidocaine Accord should be used with careful clinical assessment and monitoring.

- Allergy assessment: avoid use in patients with known lidocaine hypersensitivity. - Cardiac monitoring: observe ECG when administered intravenously or epidurally. - Dose adjustment: consider reduced doses in hepatic impairment. - Concurrent CNS depressants: use caution as additive effects may occur. - Pregnancy and lactation: use only if benefit outweighs risk (category unknown). - Store below 25°C: keep in original container, protect from light and moisture.

Lidocaine Accord may interact with several drug classes; monitoring is advised.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide): may cause severe cardiotoxicity. - Beta‑blockers: can enhance bradycardia and hypotension. - CYP3A4 inhibitors (e.g., ketoconazole): increase lidocaine plasma levels.

Moderate Interactions (Monitor Closely): - Other local anesthetics: additive neuro‑ and cardiotoxic effects. - Diuretics (e.g., furosemide): may raise plasma concentration of lidocaine. - General anesthetics (e.g., propofol): monitor for enhanced CNS depression.